Medical Devices With Indications Associated With Weight Loss-Premarket Considerations; Gui
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Medical Devices with Indications Associated with Weight Loss--Premarket Considerations." This guidance document provides recommendations regarding non-clinical testing and clinical study design for medical devi
| Agency | Health and Human Services Department, Food and Drug Administration |
|---|---|
| Document type | Notice |
| Published | 2026-03-13 |
| Summary | The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Medical Devices with Indications Associated with Weight Loss--Premarket Considerations." This guidance document provides recommendations regarding non-clinical testing and clinical study design for medical devices with indications for use associated with weight loss to support premarket submissions. The guidance also includes discussion on how FDA considers the benefit-risk analysis to support such indications. |
| Document number | 2026-04918 |
| Official record | https://www.federalregister.gov/documents/2026/03/13/2026-04918/medical-devices-with-indications-associated-with-weight-loss-premarket-considerations-guidance-for |